Omniscient Neurotechnology Pty Ltd

Omniscient Neurotechnology Pty Ltd manufactures devices focused on brain network analysis, specifically the Quicktome. This device is designed to help medical professionals analyze connectomics—complex brain network data—to improve patient care by providing clearer insights into neurological information.

The company is based in Australia. This geographic location may influence regulatory pathways, particularly for devices intended for markets with specific compliance requirements, such as the EU.

Omniscient Neurotechnology Pty Ltd’s devices, including the Quicktome, are listed in the EU’s eudamed database. This registry is used for transparency in the European medical device market, allowing stakeholders to verify device details and compliance status.

The Quicktome, one of Omniscient Neurotechnology Pty Ltd’s devices, falls under Class IIa classification. This classification is determined by risk assessment criteria, where Class IIa devices pose moderate risks that require additional measures like design controls or performance evaluations to ensure safety and efficacy.